Local News Looking at Tumors through a New LensInstitute for Systems Biology | July 2, 2021Neoadjuvant immune checkpoint blockade (ICB) is a promising treatment for melanoma and other cancer types,…kchenJuly 2, 2021 Read More
Local News Achieve Announces Completion of Target Enrollment in Phase 3 ORCA-2 Smoking Cessation Trial of CytisiniclineAchieve Life Sciences | July 2, 2021Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development…kchenJuly 2, 2021 Read More
Local News Alpine Immune Sciences to Collaborate with Merck on Immuno-Oncology StudyAlpine Immune Sciences | July 1, 2021Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments…kchenJuly 1, 2021 Read More
Local News Aurion Biotech Names Dr. Edward Holland Chief Medical AdvisorAurion Biotech | July 1, 2021Edward Holland, MD, has been named chief medical advisor of Aurion Biotech, whose mission is…kchenJuly 1, 2021 Read More
Local News BBI Faculty Conversations: Dr. Sarah BaxterBrotman Baty Institute (BBI) | June 30, 2021BBI: What is the focus of your work? How does it relate to BBI’s focus…kchenJune 30, 2021 Read More
Local News Computers Design Precise Genetic ProgramsNewswise | June 29, 2021A change of instructions in a computer program directs the computer to execute a different…kchenJune 29, 2021 Read More
Local News How RNA-Altering Drugs Might Improve Anticancer ImmunotherapiesFred Hutch | June 25, 2021In a cross-country collaboration that began a decade ago, cancer researchers have now found that…kchenJune 25, 2021 Read More
Local News Taking Aim: Mesothelin as a Novel Target for Pediatric AML TherapyFred Hutch | June 25, 2021Intensive chemotherapy is the standard of care for childhood acute myeloid leukemia (AML). Although the…kchenJune 25, 2021 Read More
Local News BRI President Dr. Jane Buckner Elected to Focis LeadershipBenaroya Research Institute at Virginia Mason (BRI) | June 25, 2021Benaroya Research Institute at Virginia Mason (BRI) is pleased to announce the election of its president,…kchenJune 25, 2021 Read More
Local News Seal Rock Therapeutics Announces Initiation of Phase 1 Clinical Trial of ASK1 Inhibitor SRT-015 for NASHSeal Rock Therapeutics | June 25, 2021Seal Rock Therapeutics, Inc., a clinical stage biotechnology company developing a platform of first-in-class and…kchenJune 25, 2021 Read More